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Commentary Towards universal systems for recombinant gene 
expression
Hans Peter Sørensen
Abstract
Recombinant gene expression is among the most important techniques used both in molecular and medical research 
and in industrial settings. Today, two recombinant expression systems are particularly well represented in the literature 
reporting on recombinant expression of specific genes. According to searches in the PubMed citation database, during 
the last 15 years 80% of all recombinant genes reported on in the literature were expressed in either the 
enterobacterium Escherichia coli or the methylotropic yeast Pichia pastoris. Nevertheless, some eukaryotic proteins are 
misfolded or inadequately posttranslationally modified in these expression systems. This situation demands 
identification of other recombinant expression systems that enable the proper expression of the remaining eukaryotic 
genes. As of now, a single universal system allowing expression of all target genes is still a distant goal. In this light, 
thorough experimental screening for systems that can yield satisfying quantity and quality of target protein is required. 
In recent years, a number of new expression systems have been described and used for protein production. Two 
systems, namely Drosophila melanogaster S2 insect cells and human embryonic kidney 293 (HEK293) cells stably 
expressing the EBNA-1 gene, show exceptional promise. The time has come to identify a few well-performing systems 
that will allow us to express, purify, and characterize entire eukaryotic genomes.
Introduction
Escherichia coli was the first host to be used for recombi-
nant gene expression almost 40 years ago [1]. Within the
past 15 years, Pichia pastoris has successfully entered the
scene and is now the second most-used host for recombi-
nant gene expression. Based on searches of the PubMed
citation database, the use of P. pastoris as an expression
host has increased from 4% to 17% of the total recombi-
nant genes reported on from 1995 to 2009 (Fig. 1). Within
the same time period, the usage of E. coli as an expression
host remained constant, with approximately 60% of the
recombinant genes reported on in journals indexed in
PubMed being expressed in E. coli. Similar trends pre-
vailed when analyzing publications in the journal Micro-
bial Cell Factories during the period from 2005 to 2009
(Fig. 1). Several other expression systems are widely used,
but to a lesser extent than E. coli and P. pastoris. So, why
are E. coli and P. pastoris particularly suited for recombi-
nant gene expression?
Protein produced from a recombinant gene in E. coli as
a soluble and functional product with high yield is the
ideal situation for most research and industrial protein
production purposes [2-4]. However, this situation is far
from realistic for all recombinant gene products. In par-
ticular, proteins derived from eukaryotes are prone to
inclusion body formation and low yields. This outcome
can be explained by the fact that the rate of gene transla-
tion in E. coli is 4- to 10-fold higher than in eukaryotes
[5]. Correct formation of disulfide bonds, protein folding,
and protein function must be carefully assessed both
when the proteins have been recombinantly produced in
E. coli in a soluble form, when they have been refolded in
vitro, or obtained from any other source [6]. Further, E.
coli should not be used as the expression system if post-
translational modifications (PTMs) are of importance for
the study or purpose of the protein because these
microbes are unable to incorporate PTMs, including N-
linked glycan chains. However , when it is able to both
properly form and posttranslationally modify a protein,
E. coli is the perfect expression host, allowing fast and
inexpensive preparation of heterologous proteins.
Many of the advantageous properties of E. coli are also
offered by P. pastoris, a methylotropic yeast that can
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exploit methanol as its only carbon source [7,8]. As com-
pared with E. coli, P. pastoris folds most eukaryotic pro-
teins more efficiently and forms disulfide bonds correctly.
Cultivation of P. pastoris in methanol-containing medium
results in strong upregulation of the promoter of the alco-
hol oxidase I (AOX1) gene. This strong and tightly regu-
lated promoter is therefore incorporated into the
majority of vectors for expression of recombinant genes
in P. pastoris [9]. When using P. pastoris, the recombinant
gene product is typically engineered with a signal
sequence to facilitate secretion, and the vectors used are
selected to integrate into the genome [9]. However, the
N-linked glycan chains added posttranslationally to pro-
teins produced in P. pastoris are substantially different
from the modifications added by mammalian cells [10].
Discussion
Given that we have these two excellent systems that
together over the last 15 years have been used to express
up to 80% of all reported recombinant genes, what else is
still needed? Imagine setting up a laboratory working to
express recombinant eukaryotic genes for biochemical
and structural analysis. Which recombinant expression
systems need to be implemented? Numerous important
factors must be considered before expression of a recom-
binant gene is attempted. What is the mass of the poly-
peptide? Multi domain proteins are typically more
difficult to produce than the alternative single domain
deletion mutants. Does the protein contain any disulfide
bonds? Proteins with disulfide bonds would most likely
not be correctly folded in E. coli [11]. Are any PTMs
required for protein folding, stability, or function, and
what is the final destination of the protein--secreted, in
the cytoplasm, or incorporated into the membrane?
Based on published studies, E. coli and  P. pastoris
enable the expression of most recombinant genes. How-
ever, one or two alternative methods would be required
to fill the final gap and enable expression of genes that
could not be expressed in either E. coli or  P. pastoris.
Here, fast and relatively inexpensive expression systems
are required. What properties that are unsatisfied by E.
coli and P. pastoris are required by these systems? First,
alternative expression systems should be able to correctly
fold the proteins that require incorporation of PTMs,
including glycan chains. Second, an alternative system
should simply enable protein production at a decent yield
when E. coli and P. pastoris expression systems fail. The
choice of expression system is also highly dependent on
the type of target protein (soluble, membrane bound,
multi domain, containing disulfide bonds, etc.), as well as
Figure 1 Percentage of all proteins reported to be produced in E. coli or P. pastoris recombinant gene expression systems based on litera-
ture searches. The PubMed citation database http://www.ncbi.nlm.nih.gov/pubmed/ or the journal Microbial Cell Factories http://http://www.micro-
bialcellfactories.com/ was searched using "recombinant protein" only or in combination with "Escherichia coli" or "Pichia pastoris" as a keyword. Data 
represent the percent of total citations found by searching using "recombinant protein" that was found when that term was combined with one of 
the two organism names. Citation data are presented for the last 15 years for PubMed and the last 5 years for Microbial Cell Factories.
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the intended use of the product. Proteins produced by
recombinant methods are typically used in structural
studies, in vitro activity assays, as antigens for antibodies,
for in vivo studies, and as drugs or as targets for generat-
ing drugs. These different applications have different
requirements for both quantity and quality.
Several important expression systems in addition to E.
coli and P. pastoris have been described. The most promi-
nent are insect cell expression systems, yeasts other than
P. pastoris, mammalian cell lines, and a few prokaryotes
other than E. coli (e.g., Bacillus subtilis) [12]. Are any of
these expression systems significantly more successful
than E. coli or P. pastoris, thereby representing an alterna-
tive to those two systems? Focusing on recombinant
genes of eukaryotic origin, two systems deserve special
attention. First, the insect cell line Drosophila melano-
gaster  Schneider 2 (S2) has been increasingly utilized
over the past few years for the production of heterologous
proteins. This system takes advantage of stable integra-
tion of up to 1,000 target gene copies following transient
transfection and antibiotic selection procedures. D. mela-
nogaster S2 cells are cultivated at 28°C without any spe-
cial requirements and yield appropriately processed and
biologically active proteins [13,14]. Second, transiently
transfected mammalian cell lines cultivated in suspension
cultures under serum-free conditions are a promising
candidate. Large-scale transfection of mammalian cells
has gained increasing interest because of it-can quickly
and inexpensively produce proteins [15]. In fact, such
processes allows for milligram to gram amounts of pro-
tein to be produced in a short period of time (2-3 weeks).
Several reports support the use of polyethylenimines for
the transfection of human embryonic kidney 293 cells
stably expressing the EBNA-1 gene (e.g., HEK293 6E)
[15,16]. These cells are potentially suited for use in high-
throughput recombinant gene expression facilities
because of the fast and easy transient transfection proce-
dure [17].
The use of screening of several expression systems
would significantly improve the hit-rate for obtaining
correctly folded, biologically active protein in high yield.
High-throughput screening facilities for recombinant
gene expression should at a minimum assess the expres-
sion of a target gene in E. coli and 2-3 eukaryotic expres-
sion systems. A laboratory with the ability to test
expression of recombinant genes in E. coli, P. pastoris,
Drosophila S2, and HEK293 EBNA systems would be per-
fectly equipped to successfully express most recombinant
target genes.
Why do we need several hosts for recombinant gene
expression? In the perfect scenario, one universal expres-
sion system would enable expression of all possible
recombinant genes in a fast, inexpensive, and proper
manner with respect to yield, folding, and biological
activity. However, because of the limitations of existing
systems, we are still far from that goal. It is therefore nec-
essary to carefully evaluate the properties of every new
target and to experimentally screen the most promising
expression hosts.
Conclusions
Because 80% of all reported recombinant genes are
expressed in either E. coli or  P. pastoris, a modern
research laboratory would be well equipped for recombi-
nant gene expression by implementing these two systems.
However, E. coli and P. pastoris are inadequate particu-
larly for expression of many eukaryotic genes. Alternative
systems useful for expression of eukaryotic genes have
been described, but are less frequently used. Here I sug-
gest the D. melanogaster S2 and HEK293 EBNA-1 expres-
sion systems as the most promising alternatives to E. coli
or P. pastoris. We are still far from the "one-host-for-all-
recombinant-gene-expression" era, and the most suitable
system for a particular target protein should be deter-
mined empirically among qualified candidates.
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